Navigation Links
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent
Date:8/15/2013

es the USPTO to consider the scope and validity of the patent based on substantial new questions of patentability raised by a third party or the USPTO.

Cadence intends to continue with the reexamination of all of the rejected claims of the '222 patent and the company is confident in its ability to make a strong case for the patentability of the rejected claims as the process continues.  Additionally, as permitted under USPTO rules, Cadence plans to file additional claims under the '222 patent. From this point forward, third parties are barred from providing additional information in this reexamination.

About OFIRMEV® (Acetaminophen) InjectionOFIRMEV (acetaminophen) injection (1000 mg / 100 mL, 10 mg / mL; for intravenous use only), Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of OFIRMEV was based on data from clinical trials in approximately 1,020 adult and 355 pediatric patients. These trials included two studies evaluating the safety and effectiveness of OFIRMEV in the treatment of pain, and one study evaluating OFIRMEV in the treatment of fever. The effectiveness of OFIRMEV for the treatment of acute pain and fever has not been studied in pediatric patients less than 2 years of age.

Important Safety InformationDo not exceed the maximum recommended daily dose of acetaminophen. Administration of acetaminophen by any route in doses higher than recommended may result in hepatic injury, including the risk of severe hepatotoxicity and death. OFIRMEV is contraindicated in patients with severe hepatic impairment, severe active liver disease or with known hypersensitivity to acetaminophen or to any of the excipients in the formulation. Acetaminophen should be used with caution in patients with the following conditions: h
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
2. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
3. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
4. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
5. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
7. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
8. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
11. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015 Zynerba Pharmaceuticals, Inc. today announced ... with the U.S. Securities and Exchange Commission (SEC) relating to ... number of shares to be offered and the price range ... Jefferies LLC and Piper Jaffray & Co. will ... Genuity Inc. and Oppenheimer & Co. Inc. will act as ...
(Date:6/30/2015)... June 30, 2015 A new analysis ... exposure to high-priced Hepatitis C medications could range ... percent of Californians infected with Hepatitis C receive treatment through ... of new Hepatitis C treatments on public programs, comes at ... price tags for drugs like Gilead Sciences, Harvoni and Sovaldi. ...
(Date:6/30/2015)...  Today, the National Mobility Equipment Dealers Association (NMEDA) ... Awareness Month Local Heroes Contest on National TV. The ... received 1.3 million votes. The sponsors for the wheelchair ... , and Valley Honda Dealers , with the ... Mobility International (VMI) and ElDorado Mobility .  ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... with West Nile Virus and populations ... PURCHASE, N.Y., Sept. 9 A recently ... by the Division of,Vector-Borne Infectious Diseases with the ... that AHCC(R) (Active Hexose Correlated,Compound) enhances host resistance ...
... Epiphany Biosciences, Inc. today,announced that a Phase 2b ... of the company,s lead compound, valomaciclovir,(EPB-348) in patients ... originally designed following an interim analysis., Fred ... with the,progress of this clinical trial and look ...
Cached Medicine Technology:Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus 2Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus 3Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN) 2
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... CCAR is ... three Recovery Community Centers in Hartford, Willimantic and Bridgeport. This month, staff member ... first Recovery Coach Manager. He is excited to take on this role of ...
(Date:6/30/2015)... NY (PRWEB) , ... June 30, 2015 , ... ... newest oncology centers are partnering to improve access to cancer prevention, screening and ... Cancer Center (LCC) have announced an affiliation that will see Roswell Park faculty ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than ... and official kick off of July as National Hot Dog Month. Americans are expected ... any other time of the year and enough to stretch from Washington D.C. to ...
(Date:6/30/2015)... ... June 30, 2015 , ... After more than five years of research ... GlobalSun (TM) — sunscreen specifically formulated for the unique skin of all people of ... the market just in time to help protect the skin of all people of ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company has ... leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, I ... now the official charity of FitAID. I AM ADAPTIVE is a non-profit whose ...
Breaking Medicine News(10 mins):Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... drinks and foods permanently destroys,enamel, CHICAGO, Sept. 4 ... harmless snacks and beverages, but improper,consumption and overuse may ... as tooth erosion, and an online member poll conducted ... feel tooth,erosion is more common today compared to five ...
... because of side effect concerns, study finds , TUESDAY, Sept. ... asthma drugs may prevent asthmatic children from getting the relief ... released in the September issue of Pediatrics , one ... about the side effects of asthma medications than their child,s ...
... Marlabs, Inc. has been named by,the Brown-Wilson ... of Top 10 BPO,healthcare revenue cycle management companies. ... to outsourcing users and,decision makers globally, garnering over ... Marlabs,s CEO Siby Vadakekkara attributes the recognition to ...
... BlueShield of South,Carolina plans to electronically integrate personal ... available in real time to BlueCross,members and their ... provider and integrator of care and,disease management services, ... Management platform available to other insurance companies. ...
... insurance calculator available in conjunction with Life ... Insurance Awareness Month, ... United States find buying life,insurance complex and confusing -- half don,t ... wrong decision (1). To help consumers learn,more about life insurance, CIGNA ...
... a novel solution; a disposable sheet that will protect travelers from the ... current ... size,of only an apple seed, these flat, oval insects that feed on ... comeback. Nearly,eradicated since World War II, they,re back in droves, infesting homes,hotels, ...
Cached Medicine News:Health News:Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion 2Health News:Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion 3Health News:Parents' Worries Hamper Kids' Asthma Treatment 2Health News:Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 2Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 2Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 3Health News:CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit 2Health News:CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit 3Health News:No Sheet: New Disposable Cover Keeps Bed Bugs at Bay 2Health News:No Sheet: New Disposable Cover Keeps Bed Bugs at Bay 3
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
M2 cemented hip stem....
Cemented foundation 450 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
Medicine Products: